The emerging therapy of this peptide represents a exciting advance in the care of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – resulting https://tirzepatidepeptide676224.jaiblogs.com/69172932/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment